Multidrug resistance-associated protein 2 (MRP2) affects hepatobiliary elimination but not the intestinal disposition of tenofovir disoproxil fumarate and its metabolites

References

• Anonymous. For first-line antiretroviral therapy: Wait and see. Tenofovir: New indication. Prescrire International. 2004; 13: 180–182
   Google Scholar
• Arimilli MN, Kim CU, Dougherty J, Mulato A, Oliyai R, Shaw JP, Cundy KC, Bischofberger N. Synthesis, in vitro biological evaluation, and oral bioavailability of 9-[(2-phosphonylmethoxy)propyl]adenine (PMPA) prodrugs. Antiviral Chemistry and Chemotherapy 1997; 8: 557–564
   Web of Science ®Google Scholar
• Cundy KC, Sueoka C, Lynch GR, Griffin L, Lee WA, Shaw JP. Pharmacokinetics and bioavailability of the anti-human immunodeficiency virus nucleotide analog 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs. Antimicrobial Agents and Chemotherapy 1998; 42: 687–690
   PubMed Web of Science ®Google Scholar
• Deeks SG, Barditch-Crovo P, Lietman PS, Hwang F, Cundy KC, Rooney JF, Hellmann NS, Safrin S, Kahn JO. Safety, pharmacokinetics, and antiretroviral activity of intravenous 9-[2-(R)-(phosphonomethoxy)propyl]-adenine, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults. Antimicrobial Agents and Chemotherapy 1998; 42: 2380–2384
   PubMed Web of Science ®Google Scholar
• Feller N, Broxterman HJ, Wahrer DCR, Pinedo HM. ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): No inhibition by intracellular glutathione depletion. Federation of European Biochemical Societies Letters 1995; 368: 385–388
   PubMed Web of Science ®Google Scholar
• Gallant JE, Deresinski S. Tenofovir disoproxil fumarate. Clinical Infectious Diseases 2003; 37: 944–950
   PubMed Web of Science ®Google Scholar
• Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, Miller MD, Coakley DF, Lu B, Toole JJ, Cheng AK. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: A 3-year randomized trial. Journal of the American Medical Association 2004; 292: 191–201
   PubMed Web of Science ®Google Scholar
• Gotoh Y, Suzuki H, Kinoshita S, Hirohashi T, Kato Y, Sugiyama Y. Involvement of an organic anion transporter (canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats. Journal of Pharmacology and Experimental Therapeutics 2000; 292: 433–439
   PubMed Web of Science ®Google Scholar
• Hogg RS, O'Shaughnessy MV, Gataric N, Yip B, Craib K, Schechter MT, Montaner JS. Decline in deaths from AIDS due to new antiretrovirals. Lancet 1997; 349: 1294
   PubMed Web of Science ®Google Scholar
• Hooijberg JH, Broxterman HJ, Kool M, Assaraf YG, Peters GJ, Noordhuis P, Scheper RJ, Borst P, Pinedo HM, Jansen G. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Research 1999; 59: 2532–2535
   PubMed Web of Science ®Google Scholar
• Kearney BP, Flaherty JF, Shah J. Tenofovir disoproxil fumarate. Clinical Pharmacokinetics 2004; 43: 595–612
   PubMed Web of Science ®Google Scholar
• McDonagh AF, Lightner DA, Boiadjiev SE, Brower JO, Norona WS. Hepatobiliary excretion of dipyrrinone sulfonates in MRP2-deficient [TR(−)] rats. Bioorganic and Medical Chemistry Letters 2002; 12: 2483–2486
   PubMed Web of Science ®Google Scholar
• Naesens L, Balzarini J, De Clercq E. Acyclic adenine nucleoside phosphonates in plasma determined by high-performance liquid chromatography with fluorescence detection. Clinical Chemistry 1992; 38: 480–485
   PubMedGoogle Scholar
• Naesens L, Bischofberger N, Augustijns P, Annaert P, Van den Mooter G, Arimilli MN, Kim CU, De Clercq E. Antiretroviral efficacy and pharmacokinetics of oral bis(isopropyloxycarbonyloxymethyl)9-(2-phosphonylmethoxypropyl)adenine in mice. Antimicrobial Agents and Chemotherapy 1998; 42: 1568–1573
   PubMed Web of Science ®Google Scholar
• Naesens L, Snoeck R, Andrei G, Balzarini J, Neyts J, De Clercq E. HPMPC (cidofovir), PMEA (adefovir) and related acyclic nucleoside phosphonate analogues: A review of their pharmacology and clinical potential in the treatment of viral infections. Antiviral Chemistry and Chemotherapy 1997; 8: 1–23
   Web of Science ®Google Scholar
• Oude Elferink R, Groen AK. Genetic defects in hepatobiliary transport. Biochimica et Biophysica Acta (BBA) — Molecular Basis of Disease 2002; 1586: 129–145
   PubMedGoogle Scholar
• Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine 1998; 338: 853–860, The HIV Outpatient Study Investigators
   PubMed Web of Science ®Google Scholar
• Paulusma CC, Bosma PJ, Zaman GJ, Bakker CT, Otter M, Scheffer GL, Scheper RJ, Borst P, Oude Elferink RP. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 1996; 271: 1126–1128
   PubMed Web of Science ®Google Scholar
• Shaw JP, Sueoko CM, Oliyai R, Lee WA, Arimilli MN, Kim CU, Cundy KC. Metabolism and pharmacokinetics of novel oral prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs. Pharmaceutical Research 1997; 14: 1824–1829
   PubMed Web of Science ®Google Scholar
• Squires K, Pozniak AL, Pierone G, Jr, Steinhart CR, Berger D, Bellos NC, Becker SL, Wulfsohn M, Miller MD, Toole JJ, Coakley DF, Cheng A. Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: A randomized trial. Annals of Internal Medicine 2003; 139: 313–320
   PubMed Web of Science ®Google Scholar
• Van Gelder J, Annaert P, Naesens L, De Clercq E, Van den MG, Kinget R, Augustijns P. Inhibition of intestinal metabolism of the antiviral ester prodrug bis(POC)-PMPA by nature-identical fruit extracts as a strategy to enhance its oral absorption: An in vitro study. Pharmaceutical Research 1999; 16: 1035–1040
   PubMed Web of Science ®Google Scholar
• Van Gelder J, Deferme S, Annaert P, Naesens L, De Clercq E, Van den Mooter G, Kinget R, Augustijns P. Increased absorption of the antiviral ester prodrug tenofovir disoproxil in rat ileum by inhibiting its intestinal metabolism. Drug Metabolism and Disposition 2000; 28: 1394–1396
   PubMed Web of Science ®Google Scholar
• Van Gelder J, Deferme S, Naesens L, De Clercq E, Van den Mooter G, Kinget R, Augustijns P. Intestinal absorption enhancement of the ester prodrug tenofovir disoproxil fumarate through modulation of the biochemical barrier by defined ester mixtures. Drug Metabolism and Disposition 2002; 30: 924–930
   PubMed Web of Science ®Google Scholar